On February 7, 2014, China Food and Drug Administration (CFDA) issued the Special Review and Approval Procedure for Innovative Medical Devices (interim), which will be put into force as of March 1, 2014. The Procedure is an approval channel

In order to implement the Medical Device Supervision and Management Ordinance (State Council Decree No. 650) and the Opinion of the State Council on the reform of drug and medical device review and approval system (Guo Fa [2015] 44), and to

In order to implement the Opinions of the State Council on the Reform of Examination and Approval System for Medicine and Medical Devices (Guo Fa [2015] No. 44) and the reform spirit of relevant administrative examination and approval syste

China Food and Drug Administration (CFDA) recently released the 2014 Drug Review Annual Report. The Annual Report describes the general situation of drug registration acceptance, review and approval in 2014, and analyzes the data of accepta

​ 绿叶生命科学集团旗下Vela Diagnostics表示，中国食品药物监督管理总局已批准其Sentosa SX游离DNA试剂盒。 该试剂盒旨在从血浆中提取血浆游离循环DNA，并开发用于RT-PCR和第二代基因测序